Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Your health records are coming to new apps. Here's why
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
23andMe CEO Anne Wojcicki files proposal to take company private as stock craters
